MU1742，5MG，SML3759-5MG，Sigma

Biochem/physiol Actions

MU1742 is an orally active, potent and selective casein kinase 1 inhibitor (CK1α/δ/ε IC50 = 7/6/28 nM; p38α IC50 >3 μM) with high kinome-wide selectivity. MU1742 inhibits CLL19-induced chemotaxis (IC50 = 200 nM; MEC1 cells) and CK1δ/ε-dependent DVL3 phosphorylation (IC50 = 200 nM post 18h treatment; HL60 cells) in cultures and in lung tissue in mice in vivo (5h post 100 mg/kg p.o. using HCl salt form).
Orally active, potent and selective casein kinase 1 (CK1, CKI) inhibitor in vitro and in vivo.